Dr. Tracy is the founder and President of NI Research (NIR), the leading publisher of independent research on the neurotherapeutics industry. NIR’s quarterly publication, NeuroPerspective, has provided comprehensive and frank overviews of the neurotherapeutics sector since 1995. It is utilized by pharmaceutical companies and venture capital professionals around the world. NIR also publishes NeuroLicensing, the annual evaluation of the ever-changing licensing environment for central nervous system companies and their programs. NIR provides consulting services to pharmaceutical companies of all sizes and to venture capital/private equity groups assessing central nervous system investment opportunities.
Dr. Tracy’s background includes 25 years of experience as a clinician and consultant in a variety of psychiatric and neurological settings. He received his Ph.D. from the University of Miami and completed his clinical training at Massachusetts General Hospital/Harvard Medical School. He has been a Research Associate in the Department of Neurology at UC Davis.